Continuous process improvement can benefit all aspects of life — from personal New Year’s resolutions to complex drug development. In a world where two-thirds of planned improvement initiatives fail, ...
Discover how quality-driven drug development and AI accelerate safer medicines, reduce risk, and improve patient outcomes.
Broadcast Retirement Network's Jeffrey Snyder discusses the use of Artificial Intelligence in the creation of new drug with Early-Stage Biotech Scientist Andrew R. Snyder, PhD. Joining me now is Dr.
Researcher Jeffrey L. Cummings M.D., ScD, from the Kirk Kerkorian School of Medicine at UNLV, has released his annual report ...
From survivorship bias to root causes! Researchers have applied AI and machine learning to every stage of the drug development process. This includes identifying targets in the body, screening ...
2d
No more guesswork in drug design—atomic-resolution method exposes what trial and error keep missing
Drug discovery still too often relies on expensive trial and error. Researchers from ICTER show there is another way—building ...
SHANGHAI, SHANGHAI, CHINA, April 30, 2026 /EINPresswire.com/ -- In today’s life sciences industry, moving a drug ...
A UNLV researcher has release his latest findings on the development of a drug to cure Alzheimer's over the last 10 years.
The Food and Drug Administration (FDA) development and approval process for drugs and medical devices involves multiple phases that ensure the safety and effectiveness of products before and after ...
Men’s Health spoke to Novo Nordisk's Thomas Kruse and Jesper Lau, the two chemists responsible for discovering ...
Bausch + Lomb CEO Brent Saunders joins 'Squawk on the Street' to discuss the impacts of artificial intelligence on healthcare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results